This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex drug molecules. Its structure, featuring trifluoromethyl groups and a urea linkage, makes it valuable in the development of potent and selective receptor antagonists. It is particularly significant in the creation of medications targeting neurological disorders, where its ability to modulate specific receptors in the brain is exploited. Additionally, its unique stereochemistry and rigid framework contribute to its efficacy in binding to biological targets, enhancing the therapeutic potential of derived drugs. Researchers also explore its use in the study of protein-ligand interactions, aiding in the design of novel treatments for various diseases.